It is with great pleasure we can announce that Dr. Nader Al-Nakouzi was awarded The FEBS Journal Best Poster Prize for the poster “Expression and regulation of oncofetal chondroitin sulfate in prostate cancer” at the Cellular signalling and cancer therapy EMBO workshop in Cavtat, Croatia 14-18 September 2018.
Co-founder and executive Chairman of the Board of directors, Dr. Mads Daugaard, are to present data on VAR2-based immunotherapy in the context of the cancer microenvironemnt at the 9th CDD Conference on Cancer, taking place in London, September 17-19, 2018. The title of the talk is “Targeting oncofetal glycosaminoglycans in the tumor microenvironment”.
VarCT Diagnostics/VAR2 Pharmaceuticals will be at the Nordic Life Science Days in Stockholm 10-12 September 2018. We look forward to meet old and new partners in the Life Science business.
Our website only uses strictly necessary cookies. Please consult our Privacy Policy for additional information on how we process your data.